European regulatory agency says Novavax Covid-19 vaccine must carry heart-side effect warning

The following is an excerpt from Reuters. The European Medicines Agency (EMA) is recommending Novavax’s Covid-19 vaccine carry a warning of the possibility of two types of heart inflammation, an added burden for a shot that has so far failed to win wide uptake. The heart conditions – myocarditis and pericarditis – should be listed […]

Read the full post at Sharyl Attkisson .

Be social. Share!
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x